This notebook integrates findings across the full pipeline — diversity metrics, clonal expansion, AUC kinetics, and edgeR differential abundance — into a unified patient-level feature matrix. We explore correlations with clinical response (CR, PR, PD) and build a composite score.
All per-patient metrics are aggregated into a single feature matrix for clinical correlation analysis, combining Product diversity, fold changes, AUC kinetics, and top clone dominance.
A composite repertoire score combining z-scored clonality, AUC, persistence, top clone fraction, and inverted Shannon entropy separates patients by clinical response.
1. Product repertoire focusing predicts response — CR patients have the lowest Shannon H, highest clonality, and most dominant top clones.
2. Post-infusion expansion kinetics separate responders from non-responders.
3. The composite score integrating multiple metrics separates clinical response groups better than any single measure.
4. These patterns are consistent across all analytical approaches (descriptive, edgeR, longitudinal, integrated).